Vera Therapeutics, Inc. (VERA)
↓ Download CSVKey ratios (FY2025)
-49.6%
Return on equity
| Metric (FY) | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 |
|---|---|---|---|---|---|---|---|
| Operating Income | -$315.47M | -$167.17M | -$102.01M | -$90.90M | -$34.40M | -$52.24M | — |
| Net Income | -$299.62M | -$152.15M | -$95.99M | -$89.06M | -$32.61M | -$53.41M | — |
| EPS (Diluted) | $-4.66 | $-2.75 | $-2.25 | $-3.35 | $-2.43 | — | — |
| Total Assets | $734.73M | $655.68M | $175.55M | $131.44M | $83.75M | $54.55M | — |
| Total Liabilities | $130.21M | $78.53M | $73.86M | $54.53M | $14.16M | $4.33M | — |
| Shareholders' Equity | $604.52M | $577.15M | $101.69M | $76.91M | $69.59M | -$89.35M | -$36.55M |
| Cash & Equivalents | $354.73M | $92.65M | $45.68M | $43.46M | $79.67M | $53.65M | — |
| Operating Cash Flow | -$241.10M | -$134.68M | -$92.18M | -$67.60M | -$23.71M | -$34.81M | — |
| Capital Expenditures | $630.0K | $972.0K | $63.0K | $62.0K | $0 | $99.0K | — |
| Shares Outstanding | 64.23M | 55.33M | 42.71M | 26.57M | 13.44M | — | — |